Biochemical bone turnover markers are useful tools to assess changes in bone metabolism in marmosets

被引:5
|
作者
Angeliewa, A
Budde, M
Schlachter, M
Hoyle, NR
Bauss, F
机构
[1] Roche Diagnost GmbH, Pharma Res, Bone Metab, D-82377 Penzberg, Germany
[2] Univ Heidelberg, Inst Pharmacol & Toxicol, D-6800 Mannheim, Germany
[3] F Hoffmann La Roche & Co Ltd, Dept Pharma Res, Anim Husb, CH-4002 Basel, Switzerland
[4] Free Univ Berlin, Inst Anim Protect Behav & Lab Anim, D-1000 Berlin, Germany
[5] F Hoffmann La Roche & Co Ltd, Pharma Dev & Biostat, CH-4002 Basel, Switzerland
[6] Roche Vitamins Ltd, Basel, Switzerland
[7] Roche Diagnost GmbH, Bone metab & Anaemia, Cent Diagnost, D-82377 Penzberg, Germany
关键词
biochemical markers of bone turnover; bone formation; bone resorption; ibandronate; marmosets; osteoporosis; metabolic bone diseases;
D O I
10.1007/s00774-003-0469-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was designed to investigate whether biochemical markers of bone resorption and formation could be determined in the serum and urine of marmosets (Callithrix jacchus), using standard laboratory chemistry methods and commercially available human kits. Consequently, the findings from this study will indicate whether the techniques and kits could serve as appropriate tools for assessing changes in bone turnover in this species. Two groups of animals (n = 12/group), consisting of a comparable number of young and old male and female marmosets, were given either isotonic saline or a single dose of the bisphosphonate ibandronate (0.1 mg/kg) s.c. in order to suppress bone turnover. Blood and urine were collected at baseline and 5 days after administration. Samples were analyzed for urinary (u) and serum (s) markers of bone formation (serum osteocalcin [sOC], serum N-terminal crosslinks of human pro-collagen type I [sP1NP]) and bone resorption (urinary pyridinoline [uPYD], urinary deoxypyridinoline [uDPD], serum C-terminal crosslinks of human collagen type I (C-telopeptide) [sCTX]), intact serum parathyroid hormone (iPTH) and urinary calcium and creatinine. Levels of all the markers of bone resorption and formation decreased during the study period. As expected, the bone formation markers decreased slightly less relative to the resorption markers. The most sensitive markers were sCTX (-33%; P less than or equal to 0.001) for bone resorption, and sP1NP (-3%; P less than or equal to 0.05) for bone formation. Serum PTH levels increased by 8% (P less than or equal to 0.05), demonstrating a physiological reaction to prevent changes in serum calcium. Although not all variables reached statistical significance within the tested interval, the applied methods and kits were considered suitable for evaluating bone turnover changes in marmosets. Thus, these methods and kits can be utilized not only during the course of pharmacological investigations but also as additional tools to assess the overall bone health of this species.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 50 条
  • [31] Biochemical Bone Turnover Markers: Significance in Patients with Osteoporosis
    Mihaljevic, Ivan
    Mudri, Dunja
    Smolic, Robert
    Smolic, Marina
    Tucak-Zoric, Sandra
    COLLEGIUM ANTROPOLOGICUM, 2009, 33 : 21 - 24
  • [32] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    A. Blumsohn
    F. Marin
    T. Nickelsen
    K. Brixen
    G. Sigurdsson
    J. González de la Vera
    S. Boonen
    S. Liu-Léage
    C. Barker
    R. Eastell
    Osteoporosis International, 2011, 22 : 1935 - 1946
  • [33] BIOCHEMICAL MARKERS OF BONE TURNOVER AND BONE-DENSITY IN HEALTHY POSTMENOPAUSAL WOMEN
    CAMPUSANO, C
    LOPEZ, JM
    GONZALEZ, G
    ROJAS, A
    ARTEAGA, E
    RODRIGUEZ, J
    REVISTA MEDICA DE CHILE, 1993, 121 (09) : 1000 - 1005
  • [34] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    Blumsohn, A.
    Marin, F.
    Nickelsen, T.
    Brixen, K.
    Sigurdsson, G.
    Gonzalez de la Vera, J.
    Boonen, S.
    Liu-Leage, S.
    Barker, C.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1935 - 1946
  • [35] Biochemical markers of bone turnover reflect femoral bone loss in elderly women
    DresnerPollak, R
    Parker, RA
    Poku, M
    Thompson, J
    Seibel, MJ
    Greenspan, SL
    CALCIFIED TISSUE INTERNATIONAL, 1996, 59 (05) : 328 - 333
  • [36] Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis
    Bronson, WD
    Walker, SE
    Hillman, LS
    Keisler, D
    Hoyt, T
    Allen, SH
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (05) : 929 - 935
  • [37] Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: An EPOLOS study
    Lukaszkiewicz, Jacek
    Karczmarewicz, Elibieta
    Pludowski, Pawel
    Jaworski, Maciej
    Czerwinski, Edward
    Lewinski, Andrzej
    Marcinowska-Suchowierska, Ewa
    Milewicz, Andrzej
    Spaczynski, Marek
    Lorenc, Roman S.
    MEDICAL SCIENCE MONITOR, 2008, 14 (12): : PH65 - PH70
  • [38] Bone turnover markers and bone metastases
    Seibel, M. J.
    OSTEOLOGIE, 2009, 18 (01) : 24 - 34
  • [39] The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density
    Stepan, J.
    Ish-Shalom, S.
    Hawkins, F.
    Marin, F.
    Farrerons, J.
    Kapetanos, G.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (06) : 1037 - 1038
  • [40] Serum biochemical markers of bone turnover in healthy infants and children
    Tommasi, M
    Bacciottini, L
    Benucci, A
    Brocchi, A
    Passeri, A
    Saracini, D
    DAgata, A
    Cappelli, G
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (03) : 159 - 164